RE: Atomic Substitution TechnologyI agree Libra. What I am REALLY exited about is the testing that will begin after ISA247, with the anti-cancer drugs.
I'm not sure I agree completely with "any company can sue any company". Yes, any company can file, but for the matter to go before the courts, there must be sufficient grounds.
And now to throw Teepee and friends a bone. I can't believe that you guys didn't think of this. Regarding patent risk: the risk is not patent infringement (no patent to infringe on), or lagal action (I still don't know what they can be sued for?).
The big risk, and a practice that is done all the time by big companies, is simply ignoring the little guy's patents. I.e. If Novartis can figure out how to manufacture ISA247, then they may just supply the drug without regard to Isotechnika. Of course, this would have to be after the drug is FDA approved. Then it would be up to ISA to sue Novartis for patent infringment, and has you shorters pointed out so many time, Novartis has deeper pockets. Baxpin can likely confirm that in the oilfield business, that has been done, or at least threatened upon, by the large oilfield service companies.
This is why Baxpin, Libra, Clarino, etc, etc. know that it is in ISA's best interests to team up with a big partner, and this is why we are so encouraged to see numerous large companies (18, I believe?) wanting to align themselves with ISA. So when the drug is finally approved there will a huge pharm. company, maybe Novartis themselves, with ISA. So if you want to see the stock rally, wait a month or two for this announcement. Surely we are in exiting times.